3SBio Inc. (TRSBF)
OTCMKTS · Delayed Price · Currency is USD
2.510
0.00 (0.00%)
At close: Feb 9, 2026
3SBio Employees
3SBio had 6,268 employees as of June 30, 2025. The number of employees increased by 691 or 12.39% since the number was reported on December 31, 2024.
Employees
6,268
Change
691
Growth
12.39%
Revenue / Employee
$202,082
Profits / Employee
$52,527
Market Cap
7.71B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 6,268 | 691 | 12.39% | 6,268 | 0 |
| Dec 31, 2024 | 5,577 | 166 | 3.07% | 5,577 | 0 |
| Dec 31, 2023 | 5,411 | 198 | 3.80% | 5,411 | 0 |
| Dec 31, 2022 | 5,213 | -79 | -1.49% | 5,213 | 0 |
| Dec 31, 2021 | 5,292 | -236 | -4.27% | 5,292 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Silence Therapeutics | 116 |
| Vaxart | 105 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| Nuo Therapeutics | 9 |
| ZIVO Bioscience | 7 |
| Vicapsys Life Sciences | 2 |
| Cell Source | 1 |
3SBio News
- 2 months ago - 3SBio Sells Shares, Divests Subsidiary To Boost Capital - Benzinga
- 2 months ago - China’s 3SBio seeks US$400 million in Hong Kong to boost drug pipeline - South China Morning Post
- 2 months ago - 3SBio spin-off Mandi banks on hair-loss and weight-loss drugs in Hong Kong IPO - South China Morning Post
- 3 months ago - Innovent's License Deal Fails To Excite investors - Benzinga
- 7 months ago - Pfizer, Chinese biotech firm 3SBio complete licensing deal for cancer drug - South China Morning Post
- 9 months ago - Pfizer's Mega Deal Highlights China's Rising Role In Global Pharma - Benzinga
- 9 months ago - Pfizer Thinks Bigger With 3SBio Deal - Seeking Alpha
- 9 months ago - Pfizer Inks Up to $6B Deal to Market 3SBio's Cancer Drug Outside China - Investopedia